Clinical Trials
3 trialsNCT01169298 2019-11-08
A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma
Celgene
Phase 1 Completed
NCT01724177 2018-05-29
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
Celgene
Phase 2 Completed
NCT01274533 2016-05-23
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
Columbia University
Phase 2 Completed